PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930081
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930081
Bioinformatics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of bioinformatics Market
The global bioinformatics market has emerged as a critical pillar of modern life sciences, driven by the growing need to manage, analyze, and interpret vast volumes of biological data. According to Fortune Business Insights, the bioinformatics market size was valued at USD 31.74 billion in 2025 and is projected to expand significantly to USD 38.45 billion in 2026. With increasing adoption across genomics, drug discovery, and personalized medicine, the market is forecasted to reach USD 118.25 billion by 2034, registering a strong CAGR of 15.08% during 2026-2034.
Bioinformatics integrates computational tools with biological sciences to analyze genomic, proteomic, and metabolomic data. These capabilities are increasingly vital for understanding disease mechanisms, discovering novel drug targets, and improving clinical outcomes. The rising global burden of chronic diseases and the rapid growth in clinical and genomic research are key contributors to market expansion.
Market Drivers and Growth Factors
One of the primary growth drivers of the bioinformatics market is the increased funding for genomics research by governments and private organizations. Large-scale genome sequencing initiatives generate enormous datasets that require advanced bioinformatics platforms for analysis and interpretation. For instance, investments in whole-genome sequencing programs and rare disease research are accelerating demand for bioinformatics software and services.
Additionally, bioinformatics plays a crucial role across the entire drug discovery lifecycle, including target identification, molecular modeling, toxicity prediction, and biomarker discovery. This has enabled pharmaceutical and biotechnology companies to shorten development timelines and reduce R&D costs, further driving adoption.
The COVID-19 pandemic also had a positive impact on the market. Bioinformatics tools were extensively used to analyze viral genome sequences, understand mutation patterns, and support vaccine development. Since 2021, the expanded application of these solutions in infectious disease research and clinical trials has continued to support steady market growth.
Market Trends: AI and Machine Learning Integration
A major trend shaping the global bioinformatics market is the integration of artificial intelligence (AI) and machine learning (ML). These technologies help extract meaningful insights from complex and unstructured biological datasets, improve predictive modeling, and enable personalized medicine. AI-driven bioinformatics platforms are increasingly used in genomics, epigenetics, and oncology research, enhancing accuracy and scalability in data analysis.
Market Segmentation Analysis
By Offering
Based on offerings, the market is segmented into software and services.
The software segment dominated the market, accounting for 79.67% share in 2026, due to high adoption of sequencing, data analysis, and visualization platforms in research and drug discovery. The services segment is also growing steadily, supported by rising demand from clinical research organizations and academic institutes.
By Application
By application, the market includes genomics, pharmacology, metabolomics, transcriptomics, and others.
The genomics segment held the largest share at 35.29% in 2026, driven by continuous advancements in sequencing technologies and increasing public and private investment in genomic research. Pharmacology and metabolomics also represent significant segments due to their importance in drug metabolism and therapeutic development.
By End User
In terms of end users, pharmaceutical and biotechnology companies dominated the market with a 45.13% share in 2026. This dominance is attributed to strategic collaborations, increased R&D spending, and the integration of bioinformatics into precision medicine and oncology programs.
Regional Insights
North America dominated the global bioinformatics market with a 46.23% share in 2025, supported by strong presence of leading solution providers, robust research infrastructure, and government-backed genomics initiatives.
Europe followed with notable growth due to investments in personalized medicine and next-generation sequencing.
The Asia Pacific region is expected to record the highest CAGR during the forecast period, fueled by rising clinical trials and expanding genomics research in countries such as China, Japan, and India.
Competitive Landscape
The bioinformatics market is moderately consolidated, with key players such as Illumina, QIAGEN, Thermo Fisher Scientific, Agilent Technologies, IBM Corporation, and Eurofins Scientific holding significant market positions. These companies focus on strategic partnerships, cloud-based platforms, and AI-enabled solutions to strengthen their global footprint.
Conclusion
In conclusion, the global bioinformatics market, valued at USD 31.74 billion in 2025, is set for robust expansion, reaching USD 118.25 billion by 2034. Strong investment in genomics research, technological advancements, and growing adoption in drug discovery and personalized medicine will continue to drive market growth during the forecast period.
Segmentation By Offering
- Software
- Services
By Application
- Metabolomics
- Pharmacology
- Genomics
- Transcriptomics
- Others
By End User
- Pharmaceutical & Biotechnology Companies
- CROs & Research Institutes
- Others
By Region
- North America (By Offering, Application, End-User, and Country)
- U.S.
- Canada
- Europe (By Offering, Application, End-User, and Country/Sub-Region)
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific (By Offering, Application, End-User, and Country/Sub-Region)
- Japan
- China
- India
- Australia
- Rest of Asia Pacific
- Latin America (By Offering, Application, End-User, and Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Offering, Application, End-User, and Country/Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Key Industry Developments - Mergers, Acquisitions & Partnerships
- 4.2. Technological Advancement in Bioinformatics
- 4.3. Impact of COVID-19 on the Market
5. Global Bioinformatics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Offerings
- 5.1.1. Software
- 5.1.2. Services
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Metabolomics
- 5.2.2. Pharmacology
- 5.2.3. Genomics
- 5.2.4. Transcriptomics
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Pharmaceutical & Biotechnological Companies
- 5.3.2. CROs & Research Institutes
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Bioinformatics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Offerings
- 6.1.1. Software
- 6.1.2. Services
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Metabolomics
- 6.2.2. Pharmacology
- 6.2.3. Genomics
- 6.2.4. Transcriptomics
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Pharmaceutical & Biotechnological Companies
- 6.3.2. CROs & Research Institutes
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Bioinformatics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Offerings
- 7.1.1. Software
- 7.1.2. Services
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Metabolomics
- 7.2.2. Pharmacology
- 7.2.3. Genomics
- 7.2.4. Transcriptomics
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Pharmaceutical & Biotechnological Companies
- 7.3.2. CROs & Research Institutes
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Rest of Europe
8. Asia Pacific Bioinformatics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Offerings
- 8.1.1. Software
- 8.1.2. Services
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Metabolomics
- 8.2.2. Pharmacology
- 8.2.3. Genomics
- 8.2.4. Transcriptomics
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Pharmaceutical & Biotechnological Companies
- 8.3.2. CROs & Research Institutes
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Rest of Asia Pacific
9. Latin America Bioinformatics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Offerings
- 9.1.1. Software
- 9.1.2. Services
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Metabolomics
- 9.2.2. Pharmacology
- 9.2.3. Genomics
- 9.2.4. Transcriptomics
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Pharmaceutical & Biotechnological Companies
- 9.3.2. CROs & Research Institutes
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Bioinformatics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Offerings
- 10.1.1. Software
- 10.1.2. Services
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Metabolomics
- 10.2.2. Pharmacology
- 10.2.3. Genomics
- 10.2.4. Transcriptomics
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Pharmaceutical & Biotechnological Companies
- 10.3.2. CROs & Research Institutes
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. DNAnexus, Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Illumina, Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Agilent Technologies, Inc.
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Thermo Fisher Scientific Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. IBM Corporation
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Labvantage - Biomax GmbH
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Genebio
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Compugen Ltd.
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Eurofins Scientific
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. QIAGEN
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.1. DNAnexus, Inc.
List of Tables
- Table 1: Global Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
- Table 2: Global Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 3: Global Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 4: Global Bioinformatics Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 5: North America Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
- Table 6: North America Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 7: North America Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 8: North America Bioinformatics Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 9: Europe Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
- Table 10: Europe Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 11: Europe Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 12: Europe Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 13: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
- Table 14: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 15: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 16: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 17: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
- Table 18: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 19: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 20: Latin America Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
- Table 22: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 23: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 24: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Bioinformatics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Bioinformatics Market Value Share (%), by Offerings, 2025 & 2034
- Figure 3: Global Bioinformatics Market Value Share (%), by Application, 2025 & 2034
- Figure 4: Global Bioinformatics Market Value Share (%), by End User, 2025 & 2034
- Figure 5: Global Bioinformatics Market Value (USD billion), by Region, 2025 & 2034
- Figure 6: North America Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
- Figure 7: North America Bioinformatics Market Value Share (%), by Offerings, 2025
- Figure 8: North America Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
- Figure 9: North America Bioinformatics Market Value Share (%), by Application, 2025
- Figure 10: North America Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
- Figure 11: North America Bioinformatics Market Value Share (%), by End User, 2025
- Figure 12: North America Bioinformatics Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Bioinformatics Market Value Share (%), By Country, 2025
- Figure 14: Europe Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
- Figure 15: Europe Bioinformatics Market Value Share (%), by Offerings, 2025
- Figure 16: Europe Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
- Figure 17: Europe Bioinformatics Market Value Share (%), by Application, 2025
- Figure 18: Europe Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
- Figure 19: Europe Bioinformatics Market Value Share (%), by End User, 2025
- Figure 20: Europe Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
- Figure 23: Asia Pacific Bioinformatics Market Value Share (%), by Offerings, 2025
- Figure 24: Asia Pacific Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
- Figure 25: Asia Pacific Bioinformatics Market Value Share (%), by Application, 2025
- Figure 26: Asia Pacific Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
- Figure 27: Asia Pacific Bioinformatics Market Value Share (%), by End User, 2025
- Figure 28: Asia Pacific Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Latin America Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
- Figure 31: Latin America Bioinformatics Market Value Share (%), by Offerings, 2025
- Figure 32: Latin America Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
- Figure 33: Latin America Bioinformatics Market Value Share (%), by Application, 2025
- Figure 34: Latin America Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
- Figure 35: Latin America Bioinformatics Market Value Share (%), by End User, 2025
- Figure 36: Latin America Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
- Figure 39: Middle East & Africa Bioinformatics Market Value Share (%), by Offerings, 2025
- Figure 40: Middle East & Africa Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
- Figure 41: Middle East & Africa Bioinformatics Market Value Share (%), by Application, 2025
- Figure 42: Middle East & Africa Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
- Figure 43: Middle East & Africa Bioinformatics Market Value Share (%), by End User, 2025
- Figure 44: Middle East & Africa Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Global Bioinformatics Market Share (%), By Company, 2025
